Publication | Open Access

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

EngineeringOncologic ImagingAdvanced Ovarian CancerMedicineTheranosticsGynecologyPhase Ii StudyRadiopharmaceutical TherapyCancer TreatmentOncologyMolecular ImagingNuclear MedicineRadiologyOvarian Cancer